BlackRock
SPRB

BlackRock’s Spruce Biosciences SPRB Stock Holding History

BlackRock’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
187,836
+170,898
+1,009% +$9.55M ﹤0.01% 3672
2026
Q1 		$1.11M Hold
16,938
– – ﹤0.01% 4306
2025
Q4 		$1.48M Buy
+16,938
New +$1.81M ﹤0.01% 4199
2025
Q2 		– Sell
-1,663
Closed -$36.2K – 5634
2025
Q1 		$36.2K Hold
1,663
– – ﹤0.01% 4982
2024
Q4 		$52.4K Hold
1,663
– – ﹤0.01% 4938
2024
Q3 		$59.2K Hold
1,663
– – ﹤0.01% 4777
2024
Q2 		$64.6K Sell
1,663
-816
-33% -$43.7K ﹤0.01% 4803
2024
Q1 		$146K Sell
2,479
-1,001
-29% -$255K ﹤0.01% 4652
2023
Q4 		$765K Buy
3,480
+33
+1% +$3.81K ﹤0.01% 4324
2023
Q3 		$584K Sell
3,447
-33
-0.9% -$5.56K ﹤0.01% 4382
2023
Q2 		$561K Buy
3,480
+1,462
+72% +$244K ﹤0.01% 4453
2023
Q1 		$334K Buy
2,018
+12
+0.6% +$2.23K ﹤0.01% 4644
2022
Q4 		$165K Buy
2,006
+8
+0.4% +$670 ﹤0.01% 4902
2022
Q3 		$205K Sell
1,998
-83
-4% -$11.6K ﹤0.01% 4965
2022
Q2 		$272K Sell
2,081
-4,980
-71% -$638K ﹤0.01% 4953
2022
Q1 		$1.06M Buy
7,061
+1,457
+26% +$271K ﹤0.01% 4646
2021
Q4 		$1.88M Sell
5,604
-13
-0.2% -$3.87K ﹤0.01% 4427
2021
Q3 		$2.53M Buy
5,617
+20
+0.4% +$12.6K ﹤0.01% 4222
2021
Q2 		$4.71M Buy
5,597
+993
+22% +$1.06M ﹤0.01% 3905
2021
Q1 		$5.73M Buy
4,604
+177
+4% +$272K ﹤0.01% 3877
2020
Q4 		$8.07M Buy
+4,427
New +$7.34M ﹤0.01% 3482

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

BlackRock's SPRB Position: Q2 2026 in Review

BlackRock increased its Spruce Biosciences (SPRB) stake by 1,009% in Q2 2026, buying an estimated $9.55M and bringing the position to 187,836 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3672.

BlackRock first reported a position in SPRB in Q4 2020 and has held it in 21 quarters since. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • BlackRock held 187,836 shares of Spruce Biosciences worth $10.1M as of Q2 2026.
  • BlackRock bought 170,898 Spruce Biosciences shares in Q2 2026, an estimated $9.55M.
  • Spruce Biosciences made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3672 holding.
  • BlackRock first reported a position in Spruce Biosciences in Q4 2020 and has held it in 21 quarters since.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.